Replies to post #128026 on Biotech Values

[DewDiligence]

Would expedited discovery apply just to Amphastar-Watson records or might MNTA subpoena FDA to be allowed to view their files?

The former, IMO. The hurdle for obtaining confidential intra-FDA documents (as opposed to correspondence between FDA and Amphastar) is high—almost certainly too high for the limited discovery that could occur before the decision on a preliminary injunction.